{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:19:56Z","timestamp":1778563196747,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-078054"],"award-info":[{"award-number":["AI-078054"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.115","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T16:03:23Z","timestamp":1446653003000},"page":"6570-6578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy"],"prefix":"10.1016","volume":"33","author":[{"given":"Mark T.","family":"Orr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse A.","family":"Beebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"E. Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Argilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Wei D.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie A.","family":"Reese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea N.","family":"Coler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.115_bib0185","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","article-title":"Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Murray","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0190","first-page":"4","article-title":"Novel vaccination strategies against tuberculosis","author":"Andersen","year":"2014","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0195","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0200","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","article-title":"Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis","volume":"181","author":"Bertholet","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0205","doi-asserted-by":"crossref","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2013.07.030","article-title":"Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis","volume":"172","author":"Orr","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0215","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.1102696","article-title":"The importance of adjuvant formulation in the development of a tuberculosis vaccine","volume":"188","author":"Baldwin","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0230","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen","volume":"174","author":"Santosuosso","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0235","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette\u2013Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0240","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0245","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4161\/hv.19568","article-title":"The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza","volume":"8","author":"Pedersen","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0250","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0255","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2014.005","article-title":"Intravascular staining for discrimination of vascular and tissue leukocytes","volume":"9","author":"Anderson","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ni.1826","article-title":"Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells","volume":"11","author":"Pepper","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0270","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.0611430104","article-title":"Drying a tuberculosis vaccine without freezing","volume":"104","author":"Wong","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0275","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2249.2001.01667.x","article-title":"Intranasal BCG vaccination protects BALB\/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs","volume":"126","author":"Lyadova","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0280","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis","volume":"21","author":"Hamasur","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0285","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.vaccine.2003.10.016","article-title":"Immunization with heat-killed Mycobacterium bovis bacille Calmette\u2013Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis","volume":"22","author":"Haile","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0290","doi-asserted-by":"crossref","first-page":"e63344","DOI":"10.1371\/journal.pone.0063344","article-title":"Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice","volume":"8","author":"Todoroff","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0295","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0300","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0305","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/7701","article-title":"A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection","volume":"21","author":"Jouanguy","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0310","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","article-title":"Inborn errors of IL-12\/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features","volume":"18","author":"Filipe-Santos","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0315","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/jiv055","article-title":"Interferon gamma and tumor necrosis factor are not essential parameters of CD4+ T-cell responses for vaccine control of tuberculosis","volume":"212","author":"Orr","year":"2015","journal-title":"J Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2015.10.115_bib1320","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0320","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","article-title":"Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells","volume":"192","author":"Sakai","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0325","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/17425247.2014.931936","article-title":"Intranasal formulations: promising strategy to deliver vaccines","volume":"11","author":"Riese","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0330","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.vaccine.2014.11.006","article-title":"Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008\u20132014","volume":"33","author":"Rodgers","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0335","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/mp4005029","article-title":"Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity","volume":"11","author":"Wong","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0340","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0264-410X(99)00572-1","article-title":"Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration","volume":"18","author":"Baldridge","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0345","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0350","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2249.2006.03296.x","article-title":"Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders","volume":"147","author":"Goldman","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0355","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/14760584.2014.936391","article-title":"Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity","volume":"13","author":"Allen","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.10.115_bib0360","doi-asserted-by":"crossref","first-page":"e41144","DOI":"10.1371\/journal.pone.0041144","article-title":"Glucopyranosyl lipid adjuvant (GLA), a synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140","volume":"7","author":"Arias","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T21:56:08Z","timestamp":1537221368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":37,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15015716"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.115","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}